Report overview
In the medicine field, gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
This report contains market size and forecasts of Gene Therapies for Cancer Treatment in Global, including the following market information:
Global Gene Therapies for Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gene Therapies for Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Somatic Cell Gene Therapy (SCGT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics and Ziopharm Oncology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapies for Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapies for Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gene Therapies for Cancer Treatment Market Segment Percentages, by Type, 2021 (%)
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Global Gene Therapies for Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gene Therapies for Cancer Treatment Market Segment Percentages, by Application, 2021 (%)
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
Global Gene Therapies for Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gene Therapies for Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapies for Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gene Therapies for Cancer Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
